This is a preview of subscription content, log in via an institution to check access.
Reference
Fowler RA, et al. Cost-effectiveness of Dalteparin vs Unfractionated Heparin for the Prevention of Venous Thromboembolism in Critically Ill Patients. JAMA: the Journal of the American Medical Association : Nov 2014. Available from: URL: http://doi.org/10.1001/jama.2014.15101
Rights and permissions
About this article
Cite this article
Dalteparin sodium best bet for VTE prevention. PharmacoEcon Outcomes News 715, 15 (2014). https://doi.org/10.1007/s40274-014-1673-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1673-6